Answers are grounded in this paper and cite their sources.
Microneedle patches improve transdermal delivery of antibodies by enhancing mechanical strength and biomimetic design.
Microneedle (MN) patches comprise a promising platform for transdermal delivery of macromolecular therapeutics. However, achieving sufficient mechanical strength for skin penetration while maintaining high biocompatibility and efficient antibody loading remains a major challenge. In this study, we designed and developed a core–shell-structured hydrogel MN patch composed of a silk fibroin core and a protein-based shell layer for antibody loading and potential transdermal release. The latter was constructed using a fusion protein consisting of the B and C domains of Staphylococcus aureus protein A (BC) and a tyrosine-rich mussel adhesive protein (MAP), thereby enabling antibody binding via the BC domains. By harnessing biomimetic design strategies, the BC-MAP shell facilitates antibody immobilization via specific affinity interactions, while the silk fibroin core provides substantial mechanical strength: the MN patch demonstrated a penetration force approximately 4.2 times greater than that required to pierce porcine skin. Collectively, our core–shell-structured hydrogel MN patch is a promising platform for transdermal antibody delivery.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: